+1 347 708 0418
The Preclinical Imaging (In-VIVO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Preclinical Imaging (In-VIVO) size is estimated to be USD 797.9 million in 2026 from USD 699.4 million in 2020, with a change XX% between 2020 and 2021. The global Preclinical Imaging (In-VIVO) market size is expected to grow at a CAGR of 3.3% for the next five years.
Market segmentation
Preclinical Imaging (In-VIVO) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Equipment
Reagent
Market segment by Application, can be divided into
Oncology
Cardio and Vascular
Neurology
Others
Market segment by players, this report covers
PerkinElmer
Bruker Corporation
FUJIFILM Holdings
Mediso
MILabs B.V.
MR Solutions
Aspect Imaging
LI-COR Biosciences
Trifoil Imaging
Miltenyi Biotec
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Preclinical Imaging (In-VIVO) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Preclinical Imaging (In-VIVO), with revenue, gross margin and global market share of Preclinical Imaging (In-VIVO) from 2019 to 2021.
Chapter 3, the Preclinical Imaging (In-VIVO) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Preclinical Imaging (In-VIVO) market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Preclinical Imaging (In-VIVO) research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Preclinical Imaging (In-VIVO)
1.2 Classification of Preclinical Imaging (In-VIVO) by Type
1.2.1 Overview: Global Preclinical Imaging (In-VIVO) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Preclinical Imaging (In-VIVO) Revenue Market Share by Type in 2020
1.2.3 Equipment
1.2.4 Reagent
1.3 Global Preclinical Imaging (In-VIVO) Market by Application
1.3.1 Overview: Global Preclinical Imaging (In-VIVO) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Cardio and Vascular
1.3.4 Neurology
1.3.5 Others
1.4 Global Preclinical Imaging (In-VIVO) Market Size & Forecast
1.5 Global Preclinical Imaging (In-VIVO) Market Size and Forecast by Region
1.5.1 Global Preclinical Imaging (In-VIVO) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Preclinical Imaging (In-VIVO) Market Size by Region, (2016-2021)
1.5.3 North America Preclinical Imaging (In-VIVO) Market Size and Prospect (2016-2026)
1.5.4 Europe Preclinical Imaging (In-VIVO) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size and Prospect (2016-2026)
1.5.6 South America Preclinical Imaging (In-VIVO) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Preclinical Imaging (In-VIVO) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Preclinical Imaging (In-VIVO) Market Drivers
1.6.2 Preclinical Imaging (In-VIVO) Market Restraints
1.6.3 Preclinical Imaging (In-VIVO) Trends Analysis
2 Company Profiles
2.1 PerkinElmer
2.1.1 PerkinElmer Details
2.1.2 PerkinElmer Major Business
2.1.3 PerkinElmer Preclinical Imaging (In-VIVO) Product and Solutions
2.1.4 PerkinElmer Preclinical Imaging (In-VIVO) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 PerkinElmer Recent Developments and Future Plans
2.2 Bruker Corporation
2.2.1 Bruker Corporation Details
2.2.2 Bruker Corporation Major Business
2.2.3 Bruker Corporation Preclinical Imaging (In-VIVO) Product and Solutions
2.2.4 Bruker Corporation Preclinical Imaging (In-VIVO) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bruker Corporation Recent Developments and Future Plans
2.3 FUJIFILM Holdings
2.3.1 FUJIFILM Holdings Details
2.3.2 FUJIFILM Holdings Major Business
2.3.3 FUJIFILM Holdings Preclinical Imaging (In-VIVO) Product and Solutions
2.3.4 FUJIFILM Holdings Preclinical Imaging (In-VIVO) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 FUJIFILM Holdings Recent Developments and Future Plans
2.4 Mediso
2.4.1 Mediso Details
2.4.2 Mediso Major Business
2.4.3 Mediso Preclinical Imaging (In-VIVO) Product and Solutions
2.4.4 Mediso Preclinical Imaging (In-VIVO) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Mediso Recent Developments and Future Plans
2.5 MILabs B.V.
2.5.1 MILabs B.V. Details
2.5.2 MILabs B.V. Major Business
2.5.3 MILabs B.V. Preclinical Imaging (In-VIVO) Product and Solutions
2.5.4 MILabs B.V. Preclinical Imaging (In-VIVO) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 MILabs B.V. Recent Developments and Future Plans
2.6 MR Solutions
2.6.1 MR Solutions Details
2.6.2 MR Solutions Major Business
2.6.3 MR Solutions Preclinical Imaging (In-VIVO) Product and Solutions
2.6.4 MR Solutions Preclinical Imaging (In-VIVO) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 MR Solutions Recent Developments and Future Plans
2.7 Aspect Imaging
2.7.1 Aspect Imaging Details
2.7.2 Aspect Imaging Major Business
2.7.3 Aspect Imaging Preclinical Imaging (In-VIVO) Product and Solutions
2.7.4 Aspect Imaging Preclinical Imaging (In-VIVO) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Aspect Imaging Recent Developments and Future Plans
2.8 LI-COR Biosciences
2.8.1 LI-COR Biosciences Details
2.8.2 LI-COR Biosciences Major Business
2.8.3 LI-COR Biosciences Preclinical Imaging (In-VIVO) Product and Solutions
2.8.4 LI-COR Biosciences Preclinical Imaging (In-VIVO) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 LI-COR Biosciences Recent Developments and Future Plans
2.9 Trifoil Imaging
2.9.1 Trifoil Imaging Details
2.9.2 Trifoil Imaging Major Business
2.9.3 Trifoil Imaging Preclinical Imaging (In-VIVO) Product and Solutions
2.9.4 Trifoil Imaging Preclinical Imaging (In-VIVO) Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Trifoil Imaging Recent Developments and Future Plans
2.10 Miltenyi Biotec
2.10.1 Miltenyi Biotec Details
2.10.2 Miltenyi Biotec Major Business
2.10.3 Miltenyi Biotec Preclinical Imaging (In-VIVO) Product and Solutions
2.10.4 Miltenyi Biotec Preclinical Imaging (In-VIVO) Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Miltenyi Biotec Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Preclinical Imaging (In-VIVO) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Preclinical Imaging (In-VIVO) Players Market Share
3.2.2 Top 10 Preclinical Imaging (In-VIVO) Players Market Share
3.2.3 Market Competition Trend
3.3 Preclinical Imaging (In-VIVO) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Preclinical Imaging (In-VIVO) Revenue and Market Share by Type (2016-2021)
4.2 Global Preclinical Imaging (In-VIVO) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Preclinical Imaging (In-VIVO) Revenue Market Share by Application (2016-2021)
5.2 Preclinical Imaging (In-VIVO) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Preclinical Imaging (In-VIVO) Revenue by Type (2016-2026)
6.2 North America Preclinical Imaging (In-VIVO) Revenue by Application (2016-2026)
6.3 North America Preclinical Imaging (In-VIVO) Market Size by Country
6.3.1 North America Preclinical Imaging (In-VIVO) Revenue by Country (2016-2026)
6.3.2 United States Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
6.3.3 Canada Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
6.3.4 Mexico Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Preclinical Imaging (In-VIVO) Revenue by Type (2016-2026)
7.2 Europe Preclinical Imaging (In-VIVO) Revenue by Application (2016-2026)
7.3 Europe Preclinical Imaging (In-VIVO) Market Size by Country
7.3.1 Europe Preclinical Imaging (In-VIVO) Revenue by Country (2016-2026)
7.3.2 Germany Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
7.3.3 France Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
7.3.5 Russia Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
7.3.6 Italy Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Preclinical Imaging (In-VIVO) Revenue by Type (2016-2026)
8.2 Asia-Pacific Preclinical Imaging (In-VIVO) Revenue by Application (2016-2026)
8.3 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region
8.3.1 Asia-Pacific Preclinical Imaging (In-VIVO) Revenue by Region (2016-2026)
8.3.2 China Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
8.3.3 Japan Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
8.3.4 South Korea Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
8.3.5 India Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
8.3.7 Australia Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Preclinical Imaging (In-VIVO) Revenue by Type (2016-2026)
9.2 South America Preclinical Imaging (In-VIVO) Revenue by Application (2016-2026)
9.3 South America Preclinical Imaging (In-VIVO) Market Size by Country
9.3.1 South America Preclinical Imaging (In-VIVO) Revenue by Country (2016-2026)
9.3.2 Brazil Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
9.3.3 Argentina Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Preclinical Imaging (In-VIVO) Revenue by Type (2016-2026)
10.2 Middle East & Africa Preclinical Imaging (In-VIVO) Revenue by Application (2016-2026)
10.3 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country
10.3.1 Middle East & Africa Preclinical Imaging (In-VIVO) Revenue by Country (2016-2026)
10.3.2 Turkey Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
10.3.4 UAE Preclinical Imaging (In-VIVO) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Preclinical Imaging (In-VIVO) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Preclinical Imaging (In-VIVO) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Preclinical Imaging (In-VIVO) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Preclinical Imaging (In-VIVO) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Region (2021-2026)
Table 6. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 7. PerkinElmer Major Business
Table 8. PerkinElmer Preclinical Imaging (In-VIVO) Product and Solutions
Table 9. PerkinElmer Preclinical Imaging (In-VIVO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bruker Corporation Corporate Information, Head Office, and Major Competitors
Table 11. Bruker Corporation Major Business
Table 12. Bruker Corporation Preclinical Imaging (In-VIVO) Product and Solutions
Table 13. Bruker Corporation Preclinical Imaging (In-VIVO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. FUJIFILM Holdings Corporate Information, Head Office, and Major Competitors
Table 15. FUJIFILM Holdings Major Business
Table 16. FUJIFILM Holdings Preclinical Imaging (In-VIVO) Product and Solutions
Table 17. FUJIFILM Holdings Preclinical Imaging (In-VIVO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Mediso Corporate Information, Head Office, and Major Competitors
Table 19. Mediso Major Business
Table 20. Mediso Preclinical Imaging (In-VIVO) Product and Solutions
Table 21. Mediso Preclinical Imaging (In-VIVO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. MILabs B.V. Corporate Information, Head Office, and Major Competitors
Table 23. MILabs B.V. Major Business
Table 24. MILabs B.V. Preclinical Imaging (In-VIVO) Product and Solutions
Table 25. MILabs B.V. Preclinical Imaging (In-VIVO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. MR Solutions Corporate Information, Head Office, and Major Competitors
Table 27. MR Solutions Major Business
Table 28. MR Solutions Preclinical Imaging (In-VIVO) Product and Solutions
Table 29. MR Solutions Preclinical Imaging (In-VIVO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Aspect Imaging Corporate Information, Head Office, and Major Competitors
Table 31. Aspect Imaging Major Business
Table 32. Aspect Imaging Preclinical Imaging (In-VIVO) Product and Solutions
Table 33. Aspect Imaging Preclinical Imaging (In-VIVO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. LI-COR Biosciences Corporate Information, Head Office, and Major Competitors
Table 35. LI-COR Biosciences Major Business
Table 36. LI-COR Biosciences Preclinical Imaging (In-VIVO) Product and Solutions
Table 37. LI-COR Biosciences Preclinical Imaging (In-VIVO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Trifoil Imaging Corporate Information, Head Office, and Major Competitors
Table 39. Trifoil Imaging Major Business
Table 40. Trifoil Imaging Preclinical Imaging (In-VIVO) Product and Solutions
Table 41. Trifoil Imaging Preclinical Imaging (In-VIVO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Miltenyi Biotec Corporate Information, Head Office, and Major Competitors
Table 43. Miltenyi Biotec Major Business
Table 44. Miltenyi Biotec Preclinical Imaging (In-VIVO) Product and Solutions
Table 45. Miltenyi Biotec Preclinical Imaging (In-VIVO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Preclinical Imaging (In-VIVO) Revenue (USD Million) by Players (2019-2021)
Table 47. Global Preclinical Imaging (In-VIVO) Revenue Share by Players (2019-2021)
Table 48. Breakdown of Preclinical Imaging (In-VIVO) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Preclinical Imaging (In-VIVO) Players Head Office, Products and Services Provided
Table 50. Preclinical Imaging (In-VIVO) Mergers & Acquisitions in the Past Five Years
Table 51. Preclinical Imaging (In-VIVO) New Entrants and Expansion Plans
Table 52. Global Preclinical Imaging (In-VIVO) Revenue (USD Million) by Type (2016-2021)
Table 53. Global Preclinical Imaging (In-VIVO) Revenue Share by Type (2016-2021)
Table 54. Global Preclinical Imaging (In-VIVO) Revenue Forecast by Type (2021-2026)
Table 55. Global Preclinical Imaging (In-VIVO) Revenue by Application (2016-2021)
Table 56. Global Preclinical Imaging (In-VIVO) Revenue Forecast by Application (2021-2026)
Table 57. North America Preclinical Imaging (In-VIVO) Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Preclinical Imaging (In-VIVO) Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Preclinical Imaging (In-VIVO) Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Preclinical Imaging (In-VIVO) Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Preclinical Imaging (In-VIVO) Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Preclinical Imaging (In-VIVO) Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Preclinical Imaging (In-VIVO) Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Preclinical Imaging (In-VIVO) Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Preclinical Imaging (In-VIVO) Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Preclinical Imaging (In-VIVO) Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Preclinical Imaging (In-VIVO) Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Preclinical Imaging (In-VIVO) Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Preclinical Imaging (In-VIVO) Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Preclinical Imaging (In-VIVO) Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Preclinical Imaging (In-VIVO) Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Preclinical Imaging (In-VIVO) Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Preclinical Imaging (In-VIVO) Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Preclinical Imaging (In-VIVO) Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Preclinical Imaging (In-VIVO) Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Preclinical Imaging (In-VIVO) Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Preclinical Imaging (In-VIVO) Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Preclinical Imaging (In-VIVO) Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Preclinical Imaging (In-VIVO) Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Preclinical Imaging (In-VIVO) Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Preclinical Imaging (In-VIVO) Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Preclinical Imaging (In-VIVO) Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Preclinical Imaging (In-VIVO) Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Preclinical Imaging (In-VIVO) Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Preclinical Imaging (In-VIVO) Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Preclinical Imaging (In-VIVO) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Preclinical Imaging (In-VIVO) Picture
Figure 2. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Type in 2020
Figure 3. Equipment
Figure 4. Reagent
Figure 5. Preclinical Imaging (In-VIVO) Revenue Market Share by Application in 2020
Figure 6. Oncology Picture
Figure 7. Cardio and Vascular Picture
Figure 8. Neurology Picture
Figure 9. Others Picture
Figure 10. Global Preclinical Imaging (In-VIVO) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Preclinical Imaging (In-VIVO) Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Region (2016-2026)
Figure 13. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Region in 2020
Figure 14. North America Preclinical Imaging (In-VIVO) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Preclinical Imaging (In-VIVO) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Preclinical Imaging (In-VIVO) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Preclinical Imaging (In-VIVO) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Preclinical Imaging (In-VIVO) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Preclinical Imaging (In-VIVO) Market Drivers
Figure 20. Preclinical Imaging (In-VIVO) Market Restraints
Figure 21. Preclinical Imaging (In-VIVO) Market Trends
Figure 22. PerkinElmer Recent Developments and Future Plans
Figure 23. Bruker Corporation Recent Developments and Future Plans
Figure 24. FUJIFILM Holdings Recent Developments and Future Plans
Figure 25. Mediso Recent Developments and Future Plans
Figure 26. MILabs B.V. Recent Developments and Future Plans
Figure 27. MR Solutions Recent Developments and Future Plans
Figure 28. Aspect Imaging Recent Developments and Future Plans
Figure 29. LI-COR Biosciences Recent Developments and Future Plans
Figure 30. Trifoil Imaging Recent Developments and Future Plans
Figure 31. Miltenyi Biotec Recent Developments and Future Plans
Figure 32. Global Preclinical Imaging (In-VIVO) Revenue Share by Players in 2020
Figure 33. Preclinical Imaging (In-VIVO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Preclinical Imaging (In-VIVO) Revenue Market Share in 2020
Figure 35. Global Top 10 Players Preclinical Imaging (In-VIVO) Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Preclinical Imaging (In-VIVO) Revenue Share by Type in 2020
Figure 38. Global Preclinical Imaging (In-VIVO) Market Share Forecast by Type (2021-2026)
Figure 39. Global Preclinical Imaging (In-VIVO) Revenue Share by Application in 2020
Figure 40. Global Preclinical Imaging (In-VIVO) Market Share Forecast by Application (2021-2026)
Figure 41. North America Preclinical Imaging (In-VIVO) Sales Market Share by Type (2016-2026)
Figure 42. North America Preclinical Imaging (In-VIVO) Sales Market Share by Application (2016-2026)
Figure 43. North America Preclinical Imaging (In-VIVO) Revenue Market Share by Country (2016-2026)
Figure 44. United States Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Preclinical Imaging (In-VIVO) Sales Market Share by Type (2016-2026)
Figure 48. Europe Preclinical Imaging (In-VIVO) Sales Market Share by Application (2016-2026)
Figure 49. Europe Preclinical Imaging (In-VIVO) Revenue Market Share by Country (2016-2026)
Figure 50. Germany Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Preclinical Imaging (In-VIVO) Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Preclinical Imaging (In-VIVO) Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Preclinical Imaging (In-VIVO) Revenue Market Share by Region (2016-2026)
Figure 58. China Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Preclinical Imaging (In-VIVO) Sales Market Share by Type (2016-2026)
Figure 65. South America Preclinical Imaging (In-VIVO) Sales Market Share by Application (2016-2026)
Figure 66. South America Preclinical Imaging (In-VIVO) Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Preclinical Imaging (In-VIVO) Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Preclinical Imaging (In-VIVO) Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Preclinical Imaging (In-VIVO) Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Preclinical Imaging (In-VIVO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Buy
